SNNNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as SNNUF
SMITH & NEPHEW PLC
Financials through fiscal 2025, year ended Dec 31, 2025
$28.84−0.22 (-0.76%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 40.3
- Dividend yield
- –
SMITH & NEPHEW PLC revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orthopaedics | $2.44B | $2.31B | $2.21B | $2.11B | $2.16B | $1.92B | $2.22B | $2.17B | $2.11B | – | 39.5% | +5.7% |
| Sports Medicine & ENT | $1.93B | $1.82B | $1.73B | $1.59B | $1.56B | $1.33B | $1.54B | $1.46B | $1.40B | – | 31.4% | +6.0% |
| Advanced Wound Management | $1.79B | $1.68B | $1.61B | $1.51B | $1.50B | $1.31B | $1.38B | $1.28B | $1.26B | – | 29.1% | +6.7% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orthopaedics, Sports Medicine & ENT | $4.37B | $4.13B | $3.94B | $3.70B | $3.72B | $3.25B | $3.76B | $3.63B | $3.51B | – | 70.9% | +5.8% |
| Advanced Wound Management | $1.79B | $1.68B | $1.61B | $1.51B | $1.50B | $1.31B | $1.38B | $1.28B | $1.26B | $1.23B | 29.1% | +6.7% |
| Advanced Wound Bioactives | – | – | – | – | – | – | – | $320.00M | $342.00M | $342.00M | – | – |
| Advanced Wound Care | – | – | – | – | – | – | – | $740.00M | $720.00M | $719.00M | – | – |
| Advanced Wound Devices | – | – | – | – | – | – | – | $215.00M | $194.00M | $172.00M | – | – |
| Trauma & Extremities | – | – | – | – | – | – | – | $493.00M | $495.00M | $475.00M | – | – |
| Arthroscopic Enabling Technologies | – | – | – | – | – | – | – | $600.00M | $615.00M | $631.00M | – | – |
| Hip Implants | – | – | – | – | – | – | – | $613.00M | $599.00M | $597.00M | – | – |
| Knee Implants | – | – | – | – | – | – | – | $1.02B | $984.00M | $932.00M | – | – |
| Other Surgical Businesses | – | – | – | – | – | – | – | $209.00M | $189.00M | $214.00M | – | – |
| Sports Medicine Joint Repair | – | – | – | – | – | – | – | $697.00M | $627.00M | $587.00M | – | – |
| Reconstruction, Sports Medicine, Trauma and Other Surgical Businesses | – | – | – | – | – | – | – | $3.63B | $3.51B | $3.44B | – | – |
| Orthopaedics, Sports Medicine and ENT and Advanced Wound Management | – | $5.81B | $5.55B | $5.22B | $5.21B | $4.56B | $5.14B | $4.90B | $4.77B | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Kingdom | – | – | – | $186.00M | $189.00M | $166.00M | $211.00M | $211.00M | $222.00M | $266.00M | – | – |
| United States | – | – | – | $2.76B | $2.66B | $2.34B | $2.55B | $2.35B | $2.31B | $2.30B | – | – |
| Other | – | – | – | – | – | – | – | – | $2.19B | $2.10B | – | – |
| Switzerland | – | – | – | $319.00M | $352.00M | $318.00M | $336.00M | $270.00M | $228.00M | – | – | – |
From the segment and revenue-disaggregation notes of Smith & Nephew's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.